antipyrine has been researched along with quinine in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (63.16) | 18.7374 |
1990's | 2 (5.26) | 18.2507 |
2000's | 7 (18.42) | 29.6817 |
2010's | 5 (13.16) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Howard, SM; Scherrer, RA | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Caron, G; Ermondi, G | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Avdeef, A; Tam, KY | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Boulos, BM; Davis, LE; Jenkins, WL | 2 |
Rajjayabun, P; Salem, SA; Shepherd, AM; Stevenson, IH | 1 |
Brendel, K; Hayes, JS | 1 |
Richens, A | 1 |
Berlin, CM; Stackman, JM; Vesell, ES | 1 |
Jenkins, MV; Perry, W | 1 |
Raaflaub, J | 1 |
El-Sayed, MA; Mohamed, YA | 1 |
Büstgens, L; Helmstaedt, D; May, B; McLean, A | 1 |
Carbon, C; Dupont, V; Emile, J; Vachon, F | 1 |
Kogoj, F | 1 |
Chinard, FP; Effros, RM | 1 |
Samková, M | 1 |
Davison, C | 1 |
Kano, S; Nishio, A | 1 |
Waser, PG | 1 |
Benet, LZ; Mehta, CS; Turner, RH | 1 |
Stricker, H | 1 |
De Ritis, G; De Rossi, P; Diamanti, E; Lauretti, MC; Maggio, F; Marchionni, G; Morabito, F; Roscioni, C | 1 |
Clark, CR; Ferry, DG; Kepple, M; Nyika, S; Wanwimolruk, S | 1 |
Davis, TM; Keeratithakul, D; Kyle, D; Looareesuwan, S; Nagachinta, B; Pukrittayakamee, S; Smith, AL; Teja-Isavadharm, P; Weber, A; White, NJ | 1 |
DE QUAY, MB; DELMONTE, J; FROMMEL, E; GOLD, P; MELKONIAN, D; RADOUCO, C; VALETTE, F | 1 |
MIZUSHIMA, Y | 1 |
NAKOSHI, T | 1 |
3 review(s) available for antipyrine and quinine
Article | Year |
---|---|
[Notes on fixed exanthemas].
Topics: Antipyrine; Bromine; Drug Hypersensitivity; Exanthema; Humans; Quinine | 1967 |
[Filling of drugs into gelatine capsules in pharmacies].
Topics: Acetanilides; Antipyrine; Aspirin; Bicarbonates; Bismuth; Caffeine; Capsules; Codeine; Dosage Forms; Methods; Nitrates; Pharmacies; Phosphates; Quinine; Salicylates; Sodium; Starch; Sulfates; Technology, Pharmaceutical | 1969 |
Salicylate metabolism in man.
Topics: Acylation; Adolescent; Aminopyrine; Animals; Antipyrine; Aspirin; Biotransformation; Brain; Dogs; Ephedrine; Female; Gastric Mucosa; Glucuronates; Haplorhini; Humans; Hydrogen-Ion Concentration; Hydrolysis; Intestinal Absorption; Kidney; Kinetics; Liver; Male; Placenta; Pregnancy; Quinine; Rats; Rheumatic Heart Disease; Salicylamides; Salicylates; Secobarbital; Thiopental | 1971 |
1 trial(s) available for antipyrine and quinine
Article | Year |
---|---|
[Comparison of the clinical activity of 2 analgesic formulations].
Topics: Adult; Analgesics; Antipyrine; Caffeine; Clinical Trials as Topic; Drug Combinations; Female; Humans; Lactose; Pain; Phenacetin; Quinine | 1981 |
34 other study(ies) available for antipyrine and quinine
Article | Year |
---|---|
Use of distribution coefficients in quantitative structure-activity relationships.
Topics: Animals; Biological Transport, Active; Cell Membrane Permeability; Colon; Hydrogen-Ion Concentration; Intestinal Absorption; Lipid Metabolism; Oxidative Phosphorylation Coupling Factors; Rats; Regression Analysis; Structure-Activity Relationship | 1977 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Transfer of drugs across the ruminal wall in goats.
Topics: Animals; Antipyrine; Diffusion; Female; Goats; Hydrogen-Ion Concentration; Male; Pentobarbital; Pharmaceutical Preparations; Quinine; Reticulum; Rumen; Salicylates | 1975 |
Reduced induction of drug metabolism in the elderly.
Topics: Adult; Aged; Antipyrine; Biotransformation; Chloral Hydrate; Female; Half-Life; Humans; Hypnotics and Sedatives; Male; Microsomes, Liver; Middle Aged; Quinine | 1978 |
N-demethylation as an example of drug metabolism in isolated rat hepatocytes.
Topics: Animals; Antipyrine; Buffers; Cells, Cultured; Citrates; Culture Media; Dansyl Compounds; Dealkylation; Glucose; In Vitro Techniques; Liver; Male; Perfusion; Pharmaceutical Preparations; Quinine; Rats; Time Factors | 1976 |
Letter: Vitamin D deficiency in rheumatoid arthritis.
Topics: Antipyrine; Arthritis, Rheumatoid; Humans; Quinine; Vitamin D Deficiency | 1975 |
Quinine-induced alterations in drug disposition.
Topics: Administration, Oral; Adult; Animals; Antipyrine; Blood Proteins; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Half-Life; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Models, Biological; Protein Binding; Quinine | 1975 |
Hepatic mixed function oxidase induction during rifampicin/isoniazid therapy in Indian vegetarians.
Topics: Antipyrine; Diet, Vegetarian; Drug Therapy, Combination; Enzyme Induction; Female; Half-Life; Humans; Hydrocortisone; India; Isoniazid; Liver; Male; Mixed Function Oxygenases; Quinine; Rifampin; Streptomycin; Tuberculosis | 1986 |
[Correlations between lipid solubility of drugs and their pharmacokinetic behavior].
Topics: Aminopyrine; Antipyrine; Barbiturates; Blood-Brain Barrier; Cell Membrane Permeability; Diffusion; Hexamethonium Compounds; Intestinal Absorption; Kidney Tubules; Kinetics; Lipids; Niacinamide; Pentobarbital; Pharmaceutical Preparations; Quinine; Salicylates; Solubility; Sulfaguanidine; Thiopental | 1970 |
Spektrophotometric estimation of quinine in combination with novalgine and in other pharmaceutical preparations.
Topics: Analgesics; Antipyrine; Drug Combinations; Methods; Methylamines; Plant Extracts; Quinine; Spectrophotometry; Sulfonic Acids; Tablets | 1972 |
Proceedings: The relation between cytochrome P450 in liver biopsies and drug metabolism in patients with liver disease and in morphine addiction.
Topics: Antipyrine; Biopsy; Cytochrome P-450 Enzyme System; Humans; Liver; Liver Diseases; Morphine Dependence; Quinine | 1974 |
[Cerebral malaria with deep coma and acute renal insufficiency. Cure after 6 days of respiratory resuscitation associated with specific treatment of the malaria].
Topics: Acute Kidney Injury; Antipyrine; Brain Diseases; Coma; Humans; Malaria; Male; Middle Aged; Neurologic Manifestations; Plasmodium falciparum; Quinine; Seizures | 1967 |
The in vivo pH of the extravascular space of the lung.
Topics: Amines; Aniline Compounds; Animals; Antipyrine; Atropine; Carbon Dioxide; Dogs; Dye Dilution Technique; Guanidines; Histamine; Hydrogen-Ion Concentration; Indicator Dilution Techniques; Ketones; Lung; Mathematics; Mescaline; Morphine; Nicotine; Oxyphenbutazone; Partial Pressure; Quinine; Radioisotope Dilution Technique; Tritium | 1969 |
Pharmacokinetics of certain drugs in the domesticated goat.
Topics: Animals; Antipyrine; Biological Transport; Blood Proteins; Body Weight; Cell Membrane Permeability; Female; Goats; Half-Life; Hydrogen-Ion Concentration; Injections, Intravenous; Kinetics; Male; Metabolism; Pentobarbital; Phenylbutazone; Protein Binding; Quinine; Salicylates; Sex Factors; Sulfanilamides; Time Factors; Tolazoline | 1972 |
[Studies on the effect of some antipyretics against endogenous pyrogen in rabbit].
Topics: Aminopyrine; Analgesics; Animals; Antipyrine; Aspirin; Fever; Leukocytes; Lipopolysaccharides; Phenacetin; Pyrogens; Quinine; Rabbits | 1971 |
[Pharmacogenetics].
Topics: Anemia, Hemolytic; Antipyrine; DNA; Drug-Related Side Effects and Adverse Reactions; Europe; Glucosephosphate Dehydrogenase Deficiency; Glutathione; Humans; Isoniazid; Pharmacogenetics; Phenacetin; Polyneuropathies; Primaquine; Quinine; Racial Groups; Sulfonamides | 1967 |
Apparent directional permeability coefficients for drug ions: in vitro intestinal perfusion studies.
Topics: Acetanilides; Aminopyrine; Aniline Compounds; Animals; Antipyrine; Biological Transport; Cell Membrane Permeability; Hydrogen-Ion Concentration; In Vitro Techniques; Intestinal Absorption; Intestine, Small; Kinetics; Male; Mathematics; Perfusion; Pharmaceutical Preparations; Pralidoxime Compounds; Quinine; Rats; Salicylamides; Salicylates; Sulfates; Time Factors | 1970 |
[In vitro study of "availability of drugs. I. Resorption from the gastrointestinal tract].
Topics: Acetanilides; Acids; Alkaloids; Amino Alcohols; Aminopyrine; Analgesics; Aniline Compounds; Antipyrine; Aspirin; Barbiturates; Benzoates; Caprylates; Diffusion; Ephedrine; Gastric Juice; Indicators and Reagents; Intestinal Absorption; Models, Biological; Permeability; Phenols; Quinine; Salicylates; Sulfamerazine; Sulfamethazine; Sulfamethoxypyridazine; Sulfathiazoles; Sulfisomidine; Sulfonamides; Tetraethylammonium Compounds; Theophylline | 1970 |
Effects of capsaicin on the pharmacokinetics of antipyrine, theophylline and quinine in rats.
Topics: Administration, Oral; Animals; Antipyrine; Capsaicin; Chromatography, High Pressure Liquid; Injections, Intravenous; Male; Quinine; Rats; Rats, Wistar; Theophylline | 1993 |
A study of the factors affecting the metabolic clearance of quinine in malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Antipyrine; Area Under Curve; Biological Availability; Female; Half-Life; Humans; Indocyanine Green; Iothalamic Acid; Malaria, Falciparum; Male; Metabolic Clearance Rate; Middle Aged; Plasmodium falciparum; Quinine | 1997 |
[P-hydroxyacetanilide; comparison of the antipyretic and analgesic effects of this compound with those of antipyrine, phenacetin, pyramidon and quinine].
Topics: Acetaminophen; Acetanilides; Aminopyrine; Analgesics; Antipyretics; Antipyrine; Phenacetin; Quinine | 1953 |
INHIBITION OF PROTEIN DENATURATION BY ANTIRHEUMATIC OR ANTIPHLOGISTIC AGENTS.
Topics: Aminopyrine; Aminosalicylic Acid; Aminosalicylic Acids; Antipyrine; Antirheumatic Agents; Aspirin; gamma-Globulins; Gentisates; Hot Temperature; Oxyphenbutazone; Pharmacology; Phenylbutazone; Protein Denaturation; Quinine; Research; Salicylamides; Serum Albumin; Sodium Salicylate; Surface-Active Agents; Ultraviolet Rays; Urea | 1964 |
[A NEW THERAPEUTIC METHOD FOR BANTI'S SYNDROME].
Topics: Anemia; Antipyrine; Drug Therapy; Epinephrine; Humans; Hypersplenism; Hypertension, Portal; Idiopathic Noncirrhotic Portal Hypertension; Liver Cirrhosis; Pancytopenia; Quinine; Splenomegaly | 1964 |